Pure Global AI
Disease / condition

Hepatocellular Carcinoma clinical trials

Free access to 1,119 studies10+ countriesUpdated daily339 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
1,119
Total trials
10+
Countries
10+
Sponsors
339
Recruiting
By phase
N/A438
Phase 2277
Phase 3102
Phase 199
Early Phase 195
By status
Recruiting339
Completed285
Unknown183
Not yet recruit...163
Terminated63
Top countries
China473
United States of America107
South Korea60
Taiwan50
France40
Top sponsors
Sun Yat-sen Univer...88
Eastern Hepatobili...28
Fudan University26
Seoul National Uni...24
Shanghai Zhongshan...21
Recent trials
Latest clinical trials for Hepatocellular Carcinoma
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
Guangxi Medical University · China
NCT06405321Recruiting
Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy
Chang Gung Memorial Hospital · Taiwan
NCT06379256Not yet recr...
A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
Akeso · China
NCT06371157Not yet recr...
Phase
Phase 3
Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy
Shanghai Zhongshan Hospital · China
NCT06382103Not yet recr...
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody
Beijing 302 Hospital
NCT06364800Not yet recr...
Phase
Phase 1
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma
Beijing 302 Hospital
NCT06364787Not yet recr...
Phase
Phase 1
HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC
Sulai Liu · China
NCT06364007Recruiting
Phase
Phase 2
Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC
Shanghai Zhongshan Hospital · China
NCT06361758Not yet recr...
Phase
Phase 2
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
Hunan Cancer Hospital · China
NCT06406634Recruiting
Phase
Phase 2
Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT
Yongyi Zeng
NCT06349317Not yet recr...
Phase
Phase 2
Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer
Peking Union Medical College H... · China
NCT06363006Recruiting
Phase
Phase 1
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
Chang Gung Memorial Hospital · Taiwan
NCT06339424Not yet recr...
Phase
Phase 2
The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic Patients
Sohag University · Egypt
NCT06328283Not yet recr...
Alectinib in Combination With Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided With Serum RNase1 and Tumor Expression of PD-L1
China Medical University Hospi... · Taiwan
NCT06354387Recruiting
Phase
Phase 1
Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)
Abramson Cancer Center at Penn... · United States of America
NCT06337162Not yet recr...
Phase
Phase 1
The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs
Egyptian Liver Hospital · Egypt
NCT06325826Recruitment ...
Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)
Sun Yat-sen University · China
NCT06313190Not yet recr...
Phase
Phase 2
Pharmacogenetic of Doxorubicin in HCC.
Rehab Werida · Saudi Arabia
NCT06313047Completed
A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
University of Alabama at Birmi... · United States of America
NCT06294548Not yet recr...
Phase
Phase 1/2
Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma
Fudan University · China
NCT06285019Recruiting
Phase
Phase 2
View all 1,119 trials →
About this profile

Access comprehensive clinical trial information for Hepatocellular Carcinoma through Pure Global AI's free database. This collection includes 1,119 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 339 trials are actively recruiting participants.

Research for Hepatocellular Carcinoma is being conducted in China, United States of America, South Korea and 7+ other countries. Leading sponsors include Sun Yat-sen University and Eastern Hepatobiliary Surgery Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 1,119 clinical trials studying Hepatocellular Carcinoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Sun Yat-sen University, Eastern Hepatobiliary Surgery Hospital, Fudan University, among others.